Located in Bergen, Norway - a center of excellence in cancer research.
BerGenBio AS
Thormohlensgt 51, 5006
Bergen, Norway
Visiting address:
Jonas Lies vei 91, 5009
Bergen, Norway
Telephone: + 47 535 01 564
E-mail: post@bergenbio.com
News & Events
2012 | 2011
December 7, 2011Promising prognostic and preclinical data for Acute Myeloid Leukemia and BerGenBio’s BGB324 at ASH
October 31, 2011BerGenBio intitiates preclinical development of novel AXL inhibitor BGB324
September 21, 2011BerGenBio appoints former Galapogos Director, Heidi Pavliska to Board as CellSelect Discovery technology delivers more novel cancer targets
July 14, 2011BerGenBio Appoints Former CRCT CEO Foden to Board as BGB324 Lead Oncology Candidate Approaches Clinic
March 3, 2011BerGenBio Secures Funding for Breakthrough CellSelect™ RNAi Cancer Research Discovery Platform